These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11585572)

  • 21. Effect of cilostazol on experimental diabetic neuropathy in the rat.
    Kihara M; Schmelzer JD; Low PA
    Diabetologia; 1995 Aug; 38(8):914-8. PubMed ID: 7589876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentoxifylline effects on nerve conduction velocity and blood flow in diabetic rats.
    Flint H; Cotter MA; Cameron NE
    Int J Exp Diabetes Res; 2000; 1(1):49-58. PubMed ID: 11469390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
    Obrosova IG; Van Huysen C; Fathallah L; Cao XC; Greene DA; Stevens MJ
    FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneurial oxygen tension in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA
    Acta Diabetol; 1994 Dec; 31(4):220-5. PubMed ID: 7888693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N
    J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.
    Nakamura J; Kato K; Hamada Y; Nakayama M; Chaya S; Nakashima E; Naruse K; Kasuya Y; Mizubayashi R; Miwa K; Yasuda Y; Kamiya H; Ienaga K; Sakakibara F; Koh N; Hotta N
    Diabetes; 1999 Oct; 48(10):2090-5. PubMed ID: 10512378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T; Nakamura J; Koh N; Sakakibara F; Hamada Y; Sasaki H; Naruse K; Nakashima E; Takeuchi N; Inukai S
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
    Dewhurst M; Omawari N; Tomlinson DR
    Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy.
    Kihara M; Low PA
    Exp Neurol; 1995 Apr; 132(2):180-5. PubMed ID: 7540553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.
    Stevens MJ; Dananberg J; Feldman EL; Lattimer SA; Kamijo M; Thomas TP; Shindo H; Sima AA; Greene DA
    J Clin Invest; 1994 Aug; 94(2):853-9. PubMed ID: 8040341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased endoneurial fluid electrolytes in normal rat sciatic nerve after aldose reductase inhibition.
    Mizisin AP; Kalichman MW; Calcutt NA; Myers RR; Powell HC
    J Neurol Sci; 1993 May; 116(1):67-72. PubMed ID: 8389817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.
    Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Sasaki H; Chaya S; Komori T; Nakashima E; Naruse K; Kato K; Takeuchi N; Kasuya Y; Hotta N
    J Pharmacol Exp Ther; 1998 Dec; 287(3):897-902. PubMed ID: 9864270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between nerve blood flow and intercapillary distance in peripheral nerve edema.
    McManis PG; Low PA; Yao JK
    Am J Physiol; 1986 Jul; 251(1 Pt 1):E92-7. PubMed ID: 3014893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor.
    Yagihashi S; Yamagishi SI; Wada Ri R; Baba M; Hohman TC; Yabe-Nishimura C; Kokai Y
    Brain; 2001 Dec; 124(Pt 12):2448-58. PubMed ID: 11701599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.
    Nagamatsu M; Nickander KK; Schmelzer JD; Raya A; Wittrock DA; Tritschler H; Low PA
    Diabetes Care; 1995 Aug; 18(8):1160-7. PubMed ID: 7587852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes].
    Kuchmerovskaia TM; Donchenko GV; Klimenko AP; Chichkovskaia GV; Pakirbaeva LV; Kozitskiĭ ZIa; Efimov AS
    Ukr Biokhim Zh (1978); 1997; 69(3):77-82. PubMed ID: 9505366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition.
    Cotter MA; Ekberg K; Wahren J; Cameron NE
    Diabetes; 2003 Jul; 52(7):1812-7. PubMed ID: 12829651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption, distribution and excretion of zenarestat, a new aldose reductase inhibitor, in rats and dogs.
    Tanaka Y; Sekiguchi M; Sawamoto T; Katami Y; Ueda T; Esumi Y; Noda K
    Xenobiotica; 1992 Jan; 22(1):57-64. PubMed ID: 1615708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.